Opportunistic infection

Types of opportunistic infections

Opportunistic infections can be caused by a wide variety of different types of pathogens. These infections can be caused by viral, bacterial, fungal, as well as parasitic pathogens.

A partial list of opportunistic pathogens and their associated effects are as follows:

Bacteria

• Atopobium vaginae is an anaerobic bacterium recognized for its role in the development of bacterial vaginosis (BV).
• Clostridioides difficile (formerly known as Clostridium difficile) is a bacteria that is known to cause gastrointestinal infection and diarrhea. It is typically associated with being the most common hospital acquired infection.
• Cutibacterium acnes (formerly Propionibacterium acnes) can act as an opportunistic agent in infections associated with implanted medical devices, forming biofilms.
• Extraintestinal pathogenic Escherichia coli (ExPEC) are E. coli strains that can lead to diseases beyond the gut, notably urinary tract infections (UTIs), meningitis, and bacteremia (bloodstream infections).
• Haemophilus influenzae is a bacterium implicated in causing illnesses such as meningitis, epiglottitis which can obstruct airways, pneumonia, otitis media affecting the ear, sinusitis involving the sinuses, and potentially leading to complications like mastoiditis, parameningeal abscess, and pericarditis.
• Klebsiella pneumoniae, a member of a group including pathogens, can be responsible for various infections in hospitalized individuals as it is frequently isolated from hospital admissions and the broader group (Enterobacteriaceae) is known to cause diverse infections.
• Legionella pneumophila is a bacterium that causes Legionnaire's disease, a respiratory infection.
• Mycobacterium avium complex (MAC) is a group of two bacteria, M. avium and M. intracellulare, that typically co-infect, leading to a lung infection called mycobacterium avium-intracellulare infection.
• Mycobacterium tuberculosis is a species of bacteria that causes tuberculosis, a respiratory infection.
• Pseudomonas aeruginosa is a bacterium that can cause respiratory infections. It is frequently associated with nosocomial infections and cystic fibrosis which can lead to organ dysfunctions and shortened life expectancy.
• Salmonella is a genus of bacteria that is known to cause gastrointestinal infections causing an inflammatory response accompanied with fever and diarrhea.
• Staphylococcus aureus is a bacterium known to cause skin infections and sepsis, among other pathologies. Notably, S. aureus has evolved several drug-resistant strains, including MRSA.
• Stenotrophomonas maltophilia has emerged as a challenging nosocomial agent frequently associated with respiratory tract infections like pneumonia and exacerbations in individuals with COPD, and can also cause bacteremia, particularly linked to central lines in vulnerable patients.
• Streptococcus pneumoniae is a bacterium that causes respiratory infections as well as meningitis and bacteremia.****
• Streptococcus pyogenes (also known as group A Streptococcus) is a bacterium that can cause a variety of conditions, including impetigo and strep throat, as well as other illnesses.

Fungi

• Aspergillus is a fungus, commonly associated with respiratory infection.
• Candida albicans is a species of fungus that is a part of the normal human microbiome. It acts as a commensal unless there is a change in concentrations. It can be associated with various conditions such as oral thrush and gastrointestinal infection.
• Coccidioides immitis is a fungus known for causing coccidioidomycosis, more commonly known as Valley Fever.
• Cryptococcus gattii: This emerging fungal pathogen can cause severe and often fatal infections, manifesting as pulmonary disease and meningitis in both immunocompromised and immunocompetent individuals.
• Cryptococcus neoformans is a fungus that causes cryptococcosis, which can lead to pulmonary infection as well as nervous system infections, like meningitis.
• Dematiaceous (pigmented) molds: These fungi are responsible for a range of diseases including phaeohyphomycosis, chromoblastomycosis, eumycotic mycetoma, invasive sinusitis, and allergic fungal sinusitis; cerebral infections can also occur.
• Fusarium species: These fungi can cause hyalohyphomycosis, particularly in immunocompromised individuals, as well as mycotic keratitis and onychomycosis.
• Hyaline (non-pigmented) molds (e.g., Acremonium, Paecilomyces, Scopulariopsis species): This group encompasses various molds, including Fusarium spp. causing hyalohyphomycosis, mycotic keratitis, and onychomycosis, as well as commonly causing pneumonia, sinusitis, and cutaneous lesions that may disseminate in neutropenic patients; Scedosporium spp. associated with sinusitis and pneumonia; Lomentospora prolificans causing a varied range of infections and disseminated disease; Scopulariopsis spp. and Acremonium spp. linked to sinopulmonary diseases; Paecilomyces variotii causing sinopulmonary disease; and Penicillium species implicated in necrotizing esophagitis and disseminated infections.
• Histoplasma capsulatum is a species of fungus known to cause histoplasmosis, which can present itself with an array of symptoms, but often involves respiratory infection.
• Lomentospora prolificans: This fungus can cause a remarkably varied range of infections and disseminated disease, including keratitis, mycotic aneurysms, external otitis, sinusitis, peritonitis, onychomycosis, and esophagitis.
• Pseudogymnoascus destructans (formerly known as Geomyces destructans) is a fungus that causes white-nose syndrome in bats.
• Microsporidia is a group of fungi that infect species across the animal kingdom, one species of which can cause microsporidiosis in immunocompromised human hosts.
• Pneumocystis jirovecii (formerly known as Pneumocystis carinii) is a fungus that causes pneumocystis pneumonia, a respiratory infection.
• Rhodotorula species: These yeasts can cause fungemia, often linked to central venous catheter use, as well as localized infections including meningitis, skin infections, ocular infections, peritonitis, and prosthetic joint infections.
• Zygomycetes (e.g., Mucor, Rhizopus, Absidia): This group can cause infections like rhinocerebral mucormycosis, and Mucor has been associated with respiratory infections; specifically, Absidia corymbifera is considered a human pathogen.

Parasites

• Cryptosporidium is a protozoan that causes the condition Cryptosporidiosis. This condition affects the gastrointestinal tract.
• Toxoplasma gondii is a protozoan, known for causing toxoplasmosis which is known to lead to impairment of the brain.

Viruses

• Adenovirus is known to cause various illnesses, including lower respiratory tract infections, pneumonia, acute respiratory diseases, epidemic keratoconjunctivitis affecting the eyes, acute hemorrhagic cystitis of the bladder, and gastroenteritis affecting the digestive system.
• LCMV causes lymphocytic choriomeningitis disease and death in immunocompromised organ-transplant patients.
• HSV is considered a member of the human herpesvirus family and is most frequently associated with immunocompromisation diseases and JAK inhibitors.
• Cytomegalovirus is considered a member of the human herpesvirus family and is most frequently associated with respiratory infection.
• Hepatitis B Virus (HBV) can lead to acute liver infection manifesting as anicteric hepatitis, icteric hepatitis, or fulminant hepatitis, and chronic infection can progress to an asymptomatic carrier state, chronic hepatitis, cirrhosis of the liver, and hepatocellular carcinoma. Severe liver damage can result in complications like jaundice, hepatic encephalopathy, ascites, gastrointestinal bleeding, and coagulopathy.
• Hepatitis C Virus (HCV) infection can become chronic, leading to liver damage that can progress to cirrhosis, portal hypertension, hepatic decompensation with encephalopathy, and hepatocellular carcinoma.
• Influenza Virus is responsible for seasonal flu epidemics and can be categorized into types affecting various hosts, such as avian (bird) flu, canine (dog) flu, swine (pig)/variant flu, and can cause pandemic flu, all generally resulting in respiratory illnesses.
• Human Metapneumovirus (HMPV) commonly causes upper and lower respiratory tract infections, with symptoms such as cough, mucous production, fever, and dyspnea, and can lead to more severe conditions like pneumonia and bronchiolitis.
• Human Papillomavirus (HPV) is the initiating force behind multiple conditions, including cutaneous and anogenital warts, which in some cases can progress to various carcinomas.
• Human polyomavirus 2 (also known as JC virus) is known to cause progressive multifocal leukoencephalopathy (PML) which affects the central nervous system.
• Human herpesvirus 8 (also known as Kaposi sarcoma-associated herpesvirus) is a virus associated with Kaposi sarcoma, a type of skin cancer.
• Human T-cell leukemia virus type 1 (HTLV-1) causes a chronic lifelong infection that can lead to general immunosuppression, uveitis affecting the eyes, dermatitis of the skin, pneumonitis in the lungs, adult T-cell leukemia, and HTLV-1 associated myelopathy also known as tropical spastic paraparesis.
• Parainfluenza Virus commonly causes upper and lower respiratory illnesses with symptoms similar to the common cold, such as fever, runny nose, cough, sneezing, and sore throat, and can also cause more serious illnesses in children including croup, bronchitis, and bronchiolitis.
• SARS-CoV-2 is the virus that causes Coronavirus Disease 2019 (COVID-19), with symptoms that can include fever, cough, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, and diarrhea.
• Varicella-Zoster Virus causes Shingles.

Opportunistic infections and HIV/AIDS

Human immunodeficiency virus (HIV) is a virus that targets the CD4 cells (a type of white blood cell) within the body's immune system and causes HIV disease or HIV/AIDS. CD4 counts within a non-affected immune system would range anywhere from 500-1500 cells per cubic millimeter of blood, while an affected immune system would show cell counts below 200. HIV infection can lead to progressively worsening immunodeficiency, a condition ideal for the development of opportunistic infection. As HIV worsens over time, the term AIDS, or acquired immunodeficiency syndrome has been used to describe the condition and extensive damage to the immune system as well as the onset and susceptibility to other illnesses. The onset of AIDS leads to respiratory and central nervous system opportunistic infections, including but not limited to pneumonia, tuberculosis and meningitis. Kaposi's sarcoma, a virally associated cancer, and non-Hodgkin's lymphoma are two types of cancers that are generally defined as AIDS malignancies. As immune function declines and HIV-infection progresses to AIDS, individuals are at an increased risk of opportunistic infections that their immune systems are no longer capable of responding properly to. Because of this, opportunistic infections are a leading cause of HIV/AIDS-related deaths.

Causes

Immunodeficiency is characterized by the absence of or the disruption in components of the immune system such as white blood cells (e.g. lymphocytes, phagocytes, etc.). These disruptions cause a decrease in immune function and result in an overall reduction of immunity against pathogens.

They can be caused by a variety of factors, including:

• Pre-existing conditions such as
  • HIV/AIDS infection
  • Systemic Lupus Erythematosus (SLE)
  • Rheumatoid arthritis
  • Multiple Sclerosis and the treatments associated with it
• Other causes include:
  • Undergoing organ transplant with the use of immunosuppressant agents
  • Receiving chemotherapy and other immunosuppressant drugs to combat cancer
  • Malnutrition
  • Genetic predisposition
  • Skin damage- cuts, burns, etc.
  • Antibiotic treatment or the misuse of antibiotics leading to disruption of the normal microbiome, thus allowing some microorganisms to outcompete others and become pathogenic (e.g. disruption of intestinal microbiota may lead to Clostridium difficile infection)
  • Medical procedures such as surgeries, endoscopies, implants, and catheterization
  • Pregnancy due to increase susceptibility and hormonal changes
  • Aging
  • Leukopenia (i.e. neutropenia and lymphocytopenia)
  • The lack of or the disruption of normal vaginal microbiota

Prevention

Since opportunistic infections can cause severe disease, much emphasis is placed on measures to prevent infection. Such a strategy usually includes restoration of the immune system as soon as possible, avoiding exposures to infectious agents, and using antimicrobial medications ("prophylactic medications") directed against specific infections.

Restoration of immune system

• In patients with HIV, starting antiretroviral therapy is recommended for restoration of the immune system and reducing the incidence rate of opportunistic infections
• In patients undergoing chemotherapy, completion of, and recovery from treatment is the primary method for immune system restoration and to prevent infection occurrence. In a select subset of high-risk patients, granulocyte colony stimulating factors (G-CSF) can be used to aid immune system recovery and infection prevention.

Avoidance of infectious exposure

• Ensure poultry is cooked to 165 °F (74 °C). Beef and pork cuts should reach an internal temperature of 145 °F (63 °C). Ground meat should be cooked to 160 °F (71 °C). Ensure juice, and dairy products are labeled as pasteurized. Eggs should be cooked until both yolks and whites are firm.
• Avoid oral exposure to feces.
• Ensure proper steps such as regular handwashing, and use of PPE are followed for the care of farm animals who are sick, specifically those experiencing diarrhea.
• Ensure proper handling and handwashing with cat feces (e.g. cat litter): source of Toxoplasma gondii, Bartonella spp.
• Avoid soil/dust in areas where there is known Histoplasma capsulatum present. If it cannot be avoided in an environment, ensure PPE is being used.
• Ensure reptiles and amphibians, their live food, and their waste are being handled properly and wash hands regularly after handling to prevent transmission of pathogens such as Salmonella.
• Avoid unprotected sexual intercourse with individuals that have sexually transmitted infections.

Prophylactic medications

Individuals at higher risk for opportunistic infections are often prescribed prophylactic medication to prevent an infection from occurring. A person's risk level for developing an opportunistic infection is approximated using the person's CD4 T-cell count and other indicators such as current medical treatments, age, and lifestyle choices. The table below provides information regarding the treatment management of common opportunistic infections.

Alternative prevention

Alternative agents can be used instead of the preferred agents. These alternative agents may be used due to an individual's allergies, availability, or clinical presentation. The alternative agents are listed in the table below.

Treatment

Due to the prevention techniques used with HIV patients, such as prophylactic medications, opportunistic infections in HIV patients have decreased in number over the past few decades. In some circumstances, where individuals are not aware they have HIV and they develop an opportunistic infection, they may be prescribed antivirals, antibiotics, or antifungals. After the infection has cleared, and to prevent it from coming back, they may be recommended to stay on that medication as well as it being coupled with another medication to ensure drug efficiency.

References

References

1. "What is an Opportunistic Infection? {{!}} NIH".
2. (2021). "StatPearls". StatPearls Publishing.
3. Sánchez, María Blanca. (2015-06-30). "Antibiotic resistance in the opportunistic pathogen Stenotrophomonas maltophilia". Frontiers in Microbiology.
4. (2025). "Clostridioides difficile infection". StatPearls Publishing.
5. (2025-01-15). "Clostridioides difficile". Wikipedia.
6. (2016-09-21). "Macrolide Resistance in ''Streptococcus pneumoniae''". Frontiers in Cellular and Infection Microbiology.
7. (July 2014). "Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen". Clinical Microbiology Reviews.
8. (2021-02-15). "Emergence of nosocomial associated opportunistic pathogens in the gut microbiome after antibiotic treatment". Antimicrobial Resistance & Infection Control.
9. (2021-08-20). "Opportunistic pathogen - Definition and Examples - Biology Online Dictionary".
10. (2009-06-18). "Study takes aim at opportunistic fungal pathogens".
11. "Scientists invent new drug candidates to treat antibiotic-resistant bacteria".
12. (2023-10-26). "Opportunistic infections".
13. (July 2019). "An update on the role of Atopobium vaginae in bacterial vaginosis: what to consider when choosing a treatment? A mini review". Archives of Gynecology and Obstetrics.
14. (July 2019). "Clostridium difficile infection: review". European Journal of Clinical Microbiology & Infectious Diseases.
15. (October 2018). "Clostridioides difficile Infection". Annals of Internal Medicine.
16. "Cutibacterium (Propionibacterium) Infections Clinical Presentation: History, Complications".
17. (2016-01-01). "Extraintestinal Pathogenic Escherichia coli, a Common Human Pathogen: Challenges for Vaccine Development and Progress in the Field". The Journal of Infectious Diseases.
18. (2025). "Haemophilus influenzae Infection". StatPearls Publishing.
19. Guentzel, M. Neal. (1996). "Escherichia, Klebsiella, Enterobacter, Serratia, Citrobacter, and Proteus". University of Texas Medical Branch at Galveston.
20. (March 2017). "Severe Pneumonia Caused by Legionella pneumophila: Differential Diagnosis and Therapeutic Considerations". Infectious Disease Clinics of North America.
21. (2016-04-08). "Legionella pneumophila: The Paradox of a Highly Sensitive Opportunistic Waterborne Pathogen Able to Persist in the Environment". Frontiers in Microbiology.
22. (2018). "''Mycobacterium avium'' complex: Adherence as a way of life". AIMS Microbiology.
23. (June 2020). "Treatment for Mycobacterium avium complex lung disease". Journal of the Formosan Medical Association = Taiwan Yi Zhi.
24. (April 2018). "Microbe Profile: Mycobacterium tuberculosis: Humanity's deadly microbial foe". Microbiology.
25. (January–February 2019). "Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies". Biotechnology Advances.
26. (2023-06-06). "Cystic Fibrosis: A Review". JAMA.
27. (January 2018). "A comprehensive review of non-enterica subspecies of Salmonella enterica". Microbiological Research.
28. (2007). "Salmonella, the host and disease: a brief review". Immunology & Cell Biology.
29. (April 2019). "Regulation of ''Staphylococcus aureus'' Virulence". Microbiology Spectrum.
30. (March 2016). "Targeting Staphylococcus aureus Toxins: A Potential form of Anti-Virulence Therapy". Toxins.
31. (2022-06-01). "Clinical challenges treating Stenotrophomonas maltophilia infections: an update". JAC-Antimicrobial Resistance.
32. (2016-09-21). "Macrolide Resistance in ''Streptococcus pneumoniae''". Frontiers in Cellular and Infection Microbiology.
33. (April 2009). "Streptococcus pneumoniae: Epidemiology, Risk Factors, and Strategies for Prevention". Seminars in Respiratory and Critical Care Medicine.
34. (December 2020). "Global genomic epidemiology of Streptococcus pyogenes". Infection, Genetics and Evolution.
35. (November 2016). "Streptococcus pyogenes adhesion and colonization". FEBS Letters.
36. (December 2019). "Aspergillus fumigatus and Aspergillosis in 2019". Clinical Microbiology Reviews.
37. (June 2020). "Opportunistic bacterial, viral and fungal infections of the lung". Medicine.
38. (August 2002). "Oral candidiasis". Postgraduate Medical Journal.
39. (April 2015). "Small intestinal fungal overgrowth". Current Gastroenterology Reports.
40. (2013-02-15). "Candida albicans pathogenicity mechanisms". Virulence.
41. (2017-09-14). "Immune Reconstitution Inflammatory Syndrome in Patients with AIDS and Disseminated Coccidioidomycosis: A Case Series and Review of the Literature". Journal of the International Association of Providers of AIDS Care.
42. (October 2011). "Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals". Microbes and Infection.
43. (July 2014). "Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis". Cold Spring Harbor Perspectives in Medicine.
44. (March 2016). "Cryptococcosis". Infectious Disease Clinics of North America.
45. (November 2003). "Epidemiology, clinical manifestations, and therapy of infections caused by dematiaceous fungi". Journal of Chemotherapy (Florence, Italy).
46. Ellis, David. (2026-04-19). "Fusarium".
47. (2023-02-06). "Non-Aspergillus Hyaline Molds: A Host-Based Perspective of Emerging Pathogenic Fungi Causing Sinopulmonary Diseases". Journal of Fungi (Basel, Switzerland).
48. (2015-06-10). "Histoplasma capsulatum, lung infection and immunity". Future Microbiology.
49. (2018). "Fungal Physiology and Immunopathogenesis". Springer International Publishing.
50. (2022-06-29). "Lomentospora prolificans: An Emerging Opportunistic Fungal Pathogen". Microorganisms.
51. (April 2018). "Fungal infections in animals: a patchwork of different situations". Medical Mycology.
52. (April 2016). "Microsporidia - Emergent Pathogens in the Global Food Chain". Trends in Parasitology.
53. (October 2015). "Pneumocystis jirovecii--from a commensal to pathogen: clinical and diagnostic review". Parasitology Research.
54. (April 2000). "Zygomycetes in human disease". Clinical Microbiology Reviews.
55. (December 2019). "''Cryptosporidium'' Infection: Epidemiology, Pathogenesis, and Differential Diagnosis". European Journal of Microbiology & Immunology.
56. (May 2018). "Cryptosporidiosis: A zoonotic disease concern". Veterinary World.
57. (July 2017). "Toxoplasma gondii: Entry, association, and physiological influence on the central nervous system". PLOS Pathogens.
58. (November 2012). "Modulation of innate immunity by Toxoplasma gondii virulence effectors". Nature Reviews. Microbiology.
59. (2019-02-01). "Presence of Toxoplasma gondii infection in brain as a potential cause of risky behavior: a report of 102 autopsy cases". European Journal of Clinical Microbiology & Infectious Diseases.
60. (2025). "Adenoviruses". StatPearls Publishing.
61. (2024-08-26). "Cellular N-Myristoyl Transferases Are Required for Mammarenavirus Multiplication". Viruses.
62. (2024-02-20). "Activation of protein kinase receptor (PKR) plays a pro-viral role in mammarenavirus-infected cells". Journal of Virology.
63. (2006-05-25). "Transmission of Lymphocytic Choriomeningitis Virus by Organ Transplantation". New England Journal of Medicine.
64. (July 2014). "Post-Transplant Complications in Recipients of Deceased and Living Donor Liver Transplant.". Transplantation.
65. (2025-01-31). "Severe Non–Donor-Derived Lymphocytic Choriomeningitis Virus Infection in 2 Solid Organ Transplant Recipients". Open Forum Infectious Diseases.
66. (2025-10-01). "N-myristoyltransferase inhibitors as candidate broad-spectrum antivirals to treat viral infections promoted by immunosuppression associated with JAK inhibitors therapy". Antiviral Research.
67. Ljungman, Per. (January 1993). "Herpes Virus Infections in Immunocompromised Patients: Problems and Therapeutic Interventions". Annals of Medicine.
68. (2016-08-03). "Herpesvirus Respiratory Infections in Immunocompromised Patients: Epidemiology, Management, and Outcomes". Seminars in Respiratory and Critical Care Medicine.
69. (2024). "Management of oral herpes simplex virus infections: The problem of resistance. A narrative review". Oral Diseases.
70. (June 2020). "Opportunistic bacterial, viral and fungal infections of the lung". Medicine.
71. (August 2019). "Cytomegalovirus (CMV) Pneumonitis: Cell Tropism, Inflammation, and Immunity". International Journal of Molecular Sciences.
72. (2016). "Cytomegalovirus". John Wiley & Sons, Ltd.
73. (2025). "Hepatitis B". StatPearls Publishing.
74. CDC. (2025-02-18). "About Influenza".
75. (2025). "Human Metapneumovirus". StatPearls Publishing.
76. (2025). "Human Papillomavirus". StatPearls Publishing.
77. (2017-11-01). "Progressive Multifocal Leukoencephalopathy and Monoclonal Antibodies: A Review". Cancer Control.
78. (2019-12-02). "Progressive Multifocal Leukoencephalopathy: Current Insights". Degenerative Neurological and Neuromuscular Disease.
79. Weissert, Robert. (2011-02-01). "Progressive multifocal leukoencephalopathy". Journal of Neuroimmunology.
80. (February 2013). "Kaposi sarcoma". Archives of Pathology & Laboratory Medicine.
81. (January 2019). "Kaposi sarcoma". Nature Reviews. Disease Primers.
82. "Human T-lymphotropic virus type 1".
83. CDC. (2024-06-18). "About Human Parainfluenza Viruses (HPIVs)".
84. link
85. CDC. (2025-01-17). "About Shingles (Herpes Zoster)".
86. (2025-10-01). "N-myristoyltransferase inhibitors as candidate broad-spectrum antivirals to treat viral infections promoted by immunosuppression associated with JAK inhibitors therapy". Antiviral Research.
87. (2025-03-12). "Evaluation of factors related to longitudinal CD4 count and the risk of death among HIV-infected patients using Bayesian joint models". BMC Public Health.
88. (March 2016). "Dissecting How CD4 T Cells Are Lost During HIV Infection". Cell Host & Microbe.
89. (November 2019). "T-cell exhaustion in HIV infection". Immunological Reviews.
90. "HIV vs. AIDS: When Does HIV Turn Into AIDS? Differences".
91. (February 2015). "Tuberculosis and HIV Coinfection". Cold Spring Harbor Perspectives in Medicine.
92. (July 2018). "Treatment for HIV-associated cryptococcal meningitis". The Cochrane Database of Systematic Reviews.
93. (August 2016). "Mapping the Epidemiology of Kaposi Sarcoma and Non-Hodgkin Lymphoma Among Children in Sub-Saharan Africa: A Review". Pediatric Blood & Cancer.
94. (2021). "StatPearls". StatPearls Publishing.
95. (2021-01-05). "The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis". Rheumatology.
96. (2023-11-01). "Incidence of opportunistic infections in patients with rheumatoid arthritis treated with different molecular-targeted drugs: A population-based retrospective cohort study". Modern Rheumatology.
97. (2018-08-01). "Infectious Complications of Multiple Sclerosis Therapies: Implications for Screening, Prophylaxis, and Management". Open Forum Infectious Diseases.
98. (2025). "Opportunistic Infection: Causes, Signs, and Treatment".
99. "Preventing Infections in People with Cancer".
100. (2022-02-23). "Underlying Causes and Co-existence of Malnutrition and Infections: An Exceedingly Common Death Risk in Cancer". Frontiers in Nutrition.
101. "New genetic disorder that causes susceptibility to opportunistic infections".
102. admin-infection. (2023-12-07). "The Most Common Bacteria Causing Wound Infections - A Comprehensive Guide".
103. (2017-03-14). "Which Antibiotics Are Most Associated with Causing Clostridium difficile Diarrhea?".
104. admin-infection. (2023-12-07). "Most Common Infection After Surgery and How to Prevent It".
105. (2024-10-21). "Urinary tract infections and catheter-associated urinary tract infections caused by Pseudomonas aeruginosa". Microbiology and Molecular Biology Reviews.
106. practicalgast. (2020-08-13). "Endoscope-Associated Infections (EAI): An Update and Future Directions".
107. (July 2018). "Implant infections: adhesion, biofilm formation and immune evasion". Nature Reviews Microbiology.
108. (2022-06-08). "Infections and Pregnancy: Effects on Maternal and Child Health". Frontiers in Cellular and Infection Microbiology.
109. Kline, K., Bowdish, D., Hartland, E., & Richardson, A. (2016). Infection in an aging population. ''Current Opinion in Microbiology'', ''29'', 63–67. https://doi.org/10.1016/j.mib.2015.11.003
110. "UpToDate".
111. (July 2014). "Anaerobes and bacterial vaginosis in pregnancy: virulence factors contributing to vaginal colonisation". International Journal of Environmental Research and Public Health.
112. (July 2013). "Bacterial vaginosis: a review on clinical trials with probiotics". The New Microbiologica.
113. (July 2013). "Bacterial vaginosis: a review on clinical trials with probiotics". The New Microbiologica.
114. (April 2011). "First report of Atopobium vaginae bacteremia with fetal loss after chorionic villus sampling". Journal of Clinical Microbiology.
115. (2015-04-23). "Clinical Infectious Disease". Cambridge University Press.
116. (December 1999). "AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study". JAMA.
117. (March 2009). "HIV-associated opportunistic infections--going, going, but not gone: the continued need for prevention and treatment guidelines". Clinical Infectious Diseases.
118. (February 2011). "Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america". Clinical Infectious Diseases.
119. (July 2006). "2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline". Journal of Clinical Oncology.
120. CDC. (2025-01-31). "Safer Food Choices".
121. (26 May 2020). "Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America".
122. CDC. (2024-08-26). "Zoonotic Diseases in Rural America".
123. "Cleaning and Disinfection Tips".
124. misgatosingles0224ld. (2023-09-03). "Should you wash your hands after scooping cat litter?".
125. CDC. (2024-11-21). "Personal Protective Equipment".
126. Medicine, Center for Veterinary. (2024-06-17). "Salmonella, Feeder Rodents, and Pet Reptiles and Amphibians – Tips You Should Know to Prevent Infection". FDA.
127. "Appendix Recommendations to Help Patients Avoid Exposure to or Infection from Opportunistic Pathogens* Sexual Exposures".
128. (2021). "Comprehensive Primary Care for Adults With HIV". Johns Hopkins University.
129. "European AIDS Clinical Society Guidelines".
130. "Table 2. Treatment of HIV-Associated Opportunistic Infections (Includes Recommendations for Acute Treatment and Secondary Prophylaxis/Chronic Suppressive/Maintenance Therapy) {{!}} NIH".
131. admin-infection. (2023-12-07). "Opportunistic Infection - A Serious Threat to Immunocompromised Individuals".
132. "European AIDS Clinical Society Guidelines".
133. Opportunistic infections. (2015). ''Rheumatology''. [https://www.neaetc.org/files/attachment/attachment/5976/EP%20-%20Opportunistic%20Infections%202021-05.pdf https://doi.org/10.1093/rheumatology/kev074]